High Risk (HR) HPV
Showing 26 - 50 of >10,000
Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,
Not yet recruiting
- Breast Cancer
- +2 more
- Abemaciclib
- +5 more
-
Boston, Massachusetts
- +7 more
Aug 14, 2023
Oropharynx Cancer Trial in France (Nivolumab, Chemoradiation)
Active, not recruiting
- Oropharynx Cancer
- Nivolumab
- Chemoradiation
-
Avignon, France
- +10 more
Apr 11, 2022
High Risk Human Papillomavirus Infection, Low Grade Squamous Intraepithelial Lesion Trial in Jinan (AHCC®capsules, Simulation of
Recruiting
- High Risk Human Papillomavirus Infection
- Low Grade Squamous Intraepithelial Lesion
- AHCC®capsules
- Simulation of AHCC®capsules
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Apr 7, 2021
Cervical Intraepithelial Neoplasia Using Self-collected
Enrolling by invitation
- HPV - Anogenital Human Papilloma Virus Infection
- Menstrual Blood Analysis (Menstrual Blood Analysis)
-
Palo Alto, CaliforniaStanford Gynecology Clinic
Dec 1, 2022
Carcinoma, Squamous Cell, Head and Neck Tumors, Oropharyngeal Tumors Trial in United States (radiation, drug, procedure)
Active, not recruiting
- Carcinoma, Squamous Cell
- +2 more
- Intensity Modulated Radiotherapy (IMRT)
- +2 more
-
Gainesville, Florida
- +4 more
Dec 15, 2021
HPV Infection, CIN1 Trial in Belgium, Estonia, United Kingdom (ChAdOx1-HPV, MVA-HPV, Placebo)
Active, not recruiting
- HPV Infection
- CIN1
- ChAdOx1-HPV
- +2 more
-
Antwerp, Belgium
- +15 more
Jan 9, 2023
Cancer of Cervix Trial in Cuernavaca (Gardasil® [Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant vaccine], Two
Completed
- Cancer of Cervix
- Gardasil® [Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant vaccine]
- +3 more
-
Cuernavaca, Morelos, MexicoInstituto Nacional de Salud Publica
Nov 24, 2021
AIDS-Related Anal Carcinoma, AIDS-Related Cervical Carcinoma, High Grade Anal Intraepithelial Neoplasia Trial in San Francisco,
Recruiting
- AIDS-Related Anal Carcinoma
- +4 more
- Biopsy
- +5 more
-
San Francisco, California
- +2 more
Jan 24, 2023
B-cell Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab, Conventional therapy)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- Blinatumomab
- Conventional therapy
-
Suzhou, Jiangsu, ChinaThe first affiliated hospital of Soochow University
Sep 26, 2022
Hepatitis C Trial in La Laguna (Screening HCV. HR-HOSPITAL, Screening HCV. HR-DDP, Screening HCV. GP-HOSPITAL)
Recruiting
- Hepatitis C
- Screening HCV. HR-HOSPITAL
- +3 more
-
La Laguna, Santa Cruz De Tenerife, SpainComplejo Hospitalario Universitario de Canarias
Feb 12, 2022
Human Papillomavirus-Related Carcinoma Trial in Austria, United States (procedure, biological, other)
Not yet recruiting
- Human Papillomavirus-Related Carcinoma
- Biospecimen Collection
- +4 more
-
Birmingham, Alabama
- +4 more
Aug 9, 2023
Novel, One Stop, Affordable, Point of Care and AI Supported
Not yet recruiting
- Cervical Cancer
- Screening
-
Harare, ZimbabweBothwell Guzha
Sep 15, 2023
Human Papillomavirus Infection Trial in Pathum Wan (SEARCH010/RV254)
Active, not recruiting
- Human Papillomavirus Infection
- SEARCH010/RV254
-
Pathum Wan, Bangkok, ThailandThe Thai Red Cross AIDS Research Centre
Apr 21, 2022
Invasive Breast Cancer Trial in Milwaukee (Cemiplimab, Paclitaxel, Carboplatin (not mandatory))
Recruiting
- Invasive Breast Cancer
- Cemiplimab
- +4 more
-
Milwaukee, WisconsinFroedtert Hospital & Medical College of Wisconsin
Apr 1, 2022
MDS, Acute Myeloid Leukemia Trial in Australia, France, Germany (Imetelstat)
Not yet recruiting
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
-
Adelaide, Australia
- +11 more
Oct 13, 2022
Advanced Breast Cancer Trial (Dalpiciclib+ letrozole +capecitabine)
Not yet recruiting
- Advanced Breast Cancer
- Dalpiciclib+ letrozole +capecitabine
- (no location specified)
Jul 21, 2022
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, High Risk
Recruiting
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +5 more
- Gemtuzumab Ozogamicin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome Trial in Australia, Netherlands,
Recruiting
- Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome
-
Duarte, California
- +12 more
Jan 4, 2023
Early Breast Cancer Trial in Spain (Doxorubicin, Cyclophosphamide, Taxane)
Active, not recruiting
- Early Breast Cancer
- Doxorubicin
- +5 more
-
Santiago De Compostela, A Coruña, Spain
- +27 more
Jul 11, 2022
Clinical Evaluation of Detection of High Risk HPV in Urine
Recruiting
- Human Papillomavirus Infection
- +17 more
-
Beijing, Beijing, China
- +2 more
Jan 21, 2022
Susceptibility and High-risk Population of Cervical Cancer
Recruiting
- Uterine Cervical Neoplasm
- +2 more
-
Wuhan, Hubei, ChinaTongji Hospital
Jul 13, 2021
High Grade Cervical Intra-epithelial Neoplasia Trial in Montreal (high risk HPV DNA testing, Active comparator: Routine
Active, not recruiting
- High Grade Cervical Intra-epithelial Neoplasia
- high risk HPV DNA testing
- Active comparator: Routine colposcopy
-
Montreal, Quebec, CanadaCentre de recherche du CHUM
Jul 28, 2021
Mucopolysaccharidosis Disorders, Hurler Syndrome, Hunter Syndrome Trial in Minneapolis (Stem Cell Transplantation, IMD
Recruiting
- Mucopolysaccharidosis Disorders
- +28 more
- Stem Cell Transplantation
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Nov 1, 2022